{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:06:11Z","timestamp":1780308371490,"version":"3.54.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijgc.2026.104712","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:00:26Z","timestamp":1776841226000},"page":"104712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Should lymph node staging be tailored according to molecular profile in endometrial cancer?"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0051-1356","authenticated-orcid":false,"given":"Oleksandra","family":"Dzyubak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Moshkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oishika","family":"Tarafdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1789-4875","authenticated-orcid":false,"given":"Justin","family":"Wei-Jia Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Maganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8439-3929","authenticated-orcid":false,"given":"Kathy","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4069-2000","authenticated-orcid":false,"given":"Anjelica","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2123-3642","authenticated-orcid":false,"given":"Sarah E.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoun Rachel","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijgc.2026.104712_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijgc.2026.104712_bib2","unstructured":"Key statistics for endometrial cancer. American Cancer Society. Accessed June 1, 2025. https:\/\/www.cancer.org\/cancer\/types\/endometrial-cancer\/about\/key-statistics.html."},{"key":"10.1016\/j.ijgc.2026.104712_bib3","unstructured":"Abu-Rustum N, Yashar C, Arend R, et al. Uterine neoplasms. version 2.2026. NCCN Clinical Practice Guidelines in Oncology. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/uterine.pdf. Accessed June 1 2025"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104712_bib4","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/S1470-2045(25)00167-6","article-title":"ESGO\u2013ESTRO\u2013ESP guidelines for the management of patients with endometrial carcinoma: update 2025","volume":"26","author":"Concin","year":"2025","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104712_bib5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","article-title":"A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study","volume":"18","author":"Rossi","year":"2017","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104712_bib6","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S1470-2045(18)30448-0","article-title":"Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial","volume":"19","author":"Frumovitz","year":"2018","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104712_bib7","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/IGC.0b013e3182954da8","article-title":"Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging","volume":"23","author":"Kim","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104712_bib8","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jmig.2019.07.030","article-title":"Sentinel lymph node mapping vs systematic lymphadenectomy for endometrial cancer: surgical morbidity and lymphatic complications","volume":"27","author":"Accorsi","year":"2020","journal-title":"J Minim Invasive Gynecol"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104712_bib9","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/S1470-2045(13)70591-6","article-title":"Classification of endometrial carcinoma: more than two types","volume":"15","author":"Murali","year":"2014","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104712_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.6004\/jnccn.2017.7066","article-title":"Evolving roles of histologic evaluation and molecular\/genomic profiling in the management of endometrial cancer","volume":"16","author":"Murali","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104712_bib11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104712_bib12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/path.5034","article-title":"The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses","volume":"244","author":"McAlpine","year":"2018","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104712_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2021.01.002","article-title":"Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study","volume":"161","author":"Kim","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104712_bib14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ygyno.2017.07.003","article-title":"Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival","volume":"146","author":"Cosgrove","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"19","key":"10.1016\/j.ijgc.2026.104712_bib15","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1158\/1078-0432.CCR-22-0713","article-title":"Microsatellite instability\u2013high endometrial cancers with MLH1 promoter hypermethylation have distinct molecular and clinical profiles","volume":"28","author":"Manning-Geist","year":"2022","journal-title":"Clin Cancer Res."},{"issue":"2","key":"10.1016\/j.ijgc.2026.104712_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"23","key":"10.1016\/j.ijgc.2026.104712_bib17","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa2216334","article-title":"Dostarlimab for primary advanced or recurrent endometrial cancer","volume":"388","author":"Mirza","year":"2023","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.ijgc.2026.104712_bib18","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1200\/JCO.2017.76.5966","article-title":"Randomized Phase II trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-trastuzumab in uterine serous carcinomas that overexpress human epidermal growth factor receptor 2\/neu","volume":"36","author":"Fader","year":"2018","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104712_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jamasurg.2020.5060","article-title":"Assessment of sentinel lymph node biopsy vs lymphadenectomy for intermediate- and high-grade endometrial cancer staging","volume":"156","author":"Cusimano","year":"2021","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104712_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"De Boer","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104712_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3390\/curroncol28010052","article-title":"Mismatch repair universal screening of endometrial cancers (MUSE) in a Canadian cohort","volume":"28","author":"Lawrence","year":"2021","journal-title":"Curr Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104712_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.5372","article-title":"Interpretation of somatic POLE mutations in endometrial carcinoma","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104712_bib24","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2021.32.e79","article-title":"MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas","volume":"32","author":"Kaneko","year":"2021","journal-title":"J Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104712_bib25","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/s41379-020-0501-8","article-title":"Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma","volume":"33","author":"Pasanen","year":"2020","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104712_bib26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/ijgc-2024-005711","article-title":"SENECA study: staging endometrial cancer based on molecular classification","volume":"34","author":"Chacon","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijgc.2026.104712_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2024.12.014","article-title":"Added prognostic value of sentinel lymph node mapping in endometrial cancer to molecular subgroups","volume":"193","author":"Siegenthaler","year":"2025","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104712_bib28","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ygyno.2022.01.025","article-title":"Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases","volume":"165","author":"Jamieson","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104712_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ygyno.2017.05.027","article-title":"Sentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations","volume":"146","author":"Holloway","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104712_bib30","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104712_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/AOG.0b013e3181aa97fc","article-title":"Evaluation of two management strategies for preoperative Grade 1 endometrial cancer","volume":"114","author":"Bernardini","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijgc.2026.104712_bib32","unstructured":"Endometrial cancer pathway map. Cancer Care Ontario. Accessed July 3, 2025. https:\/\/www.cancercareontario.ca\/en\/pathway-maps\/endometrial-cancer."},{"issue":"11","key":"10.1016\/j.ijgc.2026.104712_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2025.103124","article-title":"Endometrial carcinoma molecular classification and barriers to implementation, possible solutions, and the implications for ongoing clinical trials","volume":"47","author":"Hodgson","year":"2025","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104712_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214318","article-title":"Phenotype of POLE-mutated endometrial cancer","volume":"14","author":"Imboden","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104712_bib35","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4132\/jptm.2020.07.23","article-title":"The frequency of POLE-mutation in endometrial carcinoma and prognostic implications: a systemic review and meta-analysis","volume":"54","author":"Jumaah","year":"2020","journal-title":"J Pathol Transl Med"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:33:11Z","timestamp":1780306391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26002434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1048891X26002434"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104712","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should lymph node staging be tailored according to molecular profile in endometrial cancer?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104712"}}